David Squillacote, M.D.

Trials

Studies that name David Squillacote, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:15 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT00699582 · To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

  Eisai Inc. · completed · Refractory Partial Seizures · study director
• Ph3
  NCT00699972 · Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

  Eisai Inc. · completed · Refractory Partial Seizures · study director
• Ph3
  NCT00700310 · Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

  Eisai Inc. · completed · Refractory Partial Seizures · study director
• Ph3
  NCT00368108 · Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

  Eisai Inc. · completed · Parkinson's Disease · study director
• Ph3
  NCT00360412 · A Study of E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

  Eisai Inc. · terminated · Parkinson's Disease · study director
• Ph3
  NCT00360308 · Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

  Eisai Limited · terminated · Parkinson's Disease · study director

Grants

NIH projects from RePORTER, fetched 2026-11-12 07:15 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.